Physician profile

Steven Craig Brousell

Urology · Atlanta, GA

NPI 1679991483

$6,415.19

in general payments reported to CMS, 2019-2025

44 companies · $2,942 in 2025

The $2,942 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,882.83
Consulting Fee$2,125.00
Travel and Lodging$399.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Verathon INC. $1,250.00 2025 Npd Clinical Study
Coloplast Corp $1,003.04 2022-2024 Titan, Porges Coloplast
Olympus Winter & Ibe Gmbh $875.00 2025 Endoeye Flex Deflectable Videoscope
Procept Biorobotics Corporation $327.14 2025
Sumitomo Pharma America, INC. $288.14 2023-2025 Gemtesa, Orgovyx
Boston Scientific Corporation $257.87 2022-2024 Lumenis Pulse 120h
Medtronic, INC. $243.90 2023-2024 Interstim
Richard Wolf Medical Instruments Corp. $183.61 2023
Palette Life Sciences, INC. $173.65 2022
Endo Pharmaceuticals INC. $162.31 2022-2024 Xiaflex, Aveed
Myriad Genetic Laboratories, INC. $146.68 2022-2024 Prolaris
Teleflex LLC $132.00 2022-2025 Barrigel, Urolift
Endo USA, INC. $125.25 2024-2025 Xiaflex, Aveed
Urogen Pharma, INC. $114.94 2025
Laborie Medical Technologies Corp. $96.26 2023-2025 Optilume Bph Drug Coated Balloon Catheter
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $94.25 2022-2024 Xtandi, Myrbetriq
Abbvie INC. $70.92 2023-2024 Botox
Axonics, INC. $69.99 2022-2023 Axonics
Stryker Corporation $68.12 2024-2025 1788
Blue Earth Diagnostics $56.46 2022
Urovant Sciences INC $53.89 2022
Merck Sharp & Dohme LLC $53.21 2024 Keytruda, Welireg
Bayer Healthcare Pharmaceuticals INC. $43.67 2023-2024
Ferring Pharmaceuticals INC. $42.66 2024-2025 Adstiladrin
Astrazeneca Pharmaceuticals LP $41.55 2022-2024 Lynparza
Edap Technomed INC $41.36 2025
Agiliti Surgical, INC. $40.44 2022-2023 Sonablate, Trinity
Olympus America INC. $33.54 2024-2025 Itind System
Smith+Nephew, INC. $30.96 2024 Grafix
Terumo Medical Corporation $29.30 2025 Angio-Seal
Angiodynamics, INC. $28.81 2025 Nanoknife
180 Medical, INC. $25.73 2024
Vertex Pharmaceuticals Incorporated $23.19 2025
Tolmar, INC. $20.46 2024
Pfizer INC. $19.23 2023
Lsi Solutions INC $18.91 2024 Jnw Urtrac
Antares Pharma, INC. $18.71 2023 Nocdurna, Xyosted, Tlando
Sun Pharmaceutical Industries INC. $18.63 2024
Photocure INC $18.49 2024 Cysview
Ambu INC. $17.48 2024
Verity Pharmaceuticals INC. $17.33 2025 Trelstar
Baxter Healthcare $15.89 2023 Floseal
Civco Medical Instruments $13.88 2024
Intuitive Surgical, INC. $8.34 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven Craig Brousell

$6,415.19

in general payments reported 2019-2025

Years
2022-2025
Top company
Verathon INC.
Context
The $2,942 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/7760123/steven-craig-brousell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.